Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lifestyle1966 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A11867 | 30703836 | Dtsch Med Wochenschr | [The Diabetic Heart and Heart Failure - Update on Mechanisms and Therapy]. | 2019 | Details |
| A11907 | 30685917 | Zhonghua Gan Zang Bing Za Zhi | [Prevalence and harm of nonalcoholic fatty liver disease]. | 2019 | Details |
| A11924 | 30680167 | Food Sci Nutr | Anti-fibrotic activity of Euglena gracilis and paramylon in a mouse model of non-alcoholic steatohepatitis. | 2018 | Details |
| A11971 | 30661332 | J Exerc Nutrition Biochem | Association of hand-grip strength and non-alcoholic fatty liver disease index in older adults. | 2018 | Details |
| A12000 | 30652641 | Curr Pharm Des | Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome. | 2018 | Details |
| A12003 | 30651891 | Genes Nutr | Circulating microRNAs are associated with early childhood obesity: results of the I.Family Study. | 2019 | Details |
| A12048 | 30625285 | Annu Rev Pharmacol Toxicol | Emerging Pharmacological Targets for the Treatment of Nonalcoholic Fatty Liver Disease, Insulin Resistance, and Type 2 Diabetes. | 2019 | Details |
| A12057 | 30619993 | Hepatol Commun | Childhood Fructoholism and Fructoholic Liver Disease. | 2018 | Details |
| A12061 | 30618824 | Front Physiol | Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A12088 | 30607652 | Clin Rheumatol | Prevalence and risk factors associated with hyperuricemia among working population at high altitudes: a cross-sectional study in Western China. | 2019 | Details |
| A12089 | 30606929 | Yakugaku Zasshi | [A Multifaceted Approach regarding the Association of the DsbA-L Gene with the Risk of Obesity-related Diseases Based on Clinical Pharmacogenetics]. | 2019 | Details |
| A12100 | 30602434 | J Med Internet Res | Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study. | 2019 | Details |
| A12135 | 30588564 | Drugs | Current and Emerging Therapies for Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A12168 | 30576537 | Hum Reprod | Features of the metabolic syndrome in late adolescence are associated with impaired testicular function at 20 years of age. | 2019 | Details |
| A12172 | 30574627 | J Gastrointestin Liver Dis | Nonalcoholic Fatty Liver Disease: Status Quo. | 2018 | Details |
| A12195 | 30567368 | Int J Mol Sci | Effective Food Ingredients for Fatty Liver: Soy Protein β-Conglycinin and Fish Oil. | 2018 | Details |
| A12210 | 30561027 | Aliment Pharmacol Ther | Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non-alcoholic fatty liver disease. | 2018 | Details |
| A12266 | 30541128 | J Clin Endocrinol Metab | The Gly385(388)Arg Polymorphism of the FGFR4 Receptor Regulates Hepatic Lipogenesis Under Healthy Diet. | 2019 | Details |
| A12275 | 30537758 | Digestion | Nonalcoholic-Fatty-Liver-Disease and Nonalcoholic Steatohepatitis: Successful Development of Pharmacological Treatment Will Depend on Translational Research. | 2018 | Details |
| A12313 | 30502373 | Metabolism | Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. | 2018 | Details |
| A12327 | 30515333 | Int J Hepatol | Relationship between Experimental Diet in Rats and Nonalcoholic Hepatic Disease: Review of Literature. | 2018 | Details |
| A12348 | 30496690 | Postgrad Med | Clinical workup of fatty liver for the primary care provider. | 2018 | Details |
| A12359 | 30487357 | Exp Anim | AIM-deficient mouse fed a high-trans fat, high-cholesterol diet: a new animal model for nonalcoholic fatty liver disease. | 2018 | Details |
| A12364 | 30483909 | Dig Dis Sci | Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China. | 2018 | Details |
| A12371 | 30483536 | JGH Open | Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial. | 2017 | Details |
| A12377 | 30479664 | Therap Adv Gastroenterol | Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis. | 2018 | Details |
| A12410 | 30466956 | Clin Nutr | Lean non-alcoholic fatty liver disease. | 2018 | Details |
| A12411 | 30466676 | Med Clin North Am | The Future of Nonalcoholic Fatty Liver Disease Treatment. | 2018 | Details |
| A12423 | 30459715 | Front Endocrinol (Lausanne) | Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD. | 2018 | Details |
| A12433 | 30457067 | Proc Nutr Soc | Hepatic fatty acid synthesis and partitioning: the effect of metabolic and nutritional state. | 2018 | Details |
| A12434 | 30456918 | Diabetes Obes Metab | Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis? | 2018 | Details |
| A12436 | 30455585 | Contemp Oncol (Pozn) | Update in global trends and aetiology of hepatocellular carcinoma. | 2018 | Details |
| A12450 | 30451987 | Eur J Clin Nutr | Diet with greater inflammatory potential is associated with higher prevalence of fatty liver among US adults. | 2018 | Details |
| A12521 | 30411635 | Expert Opin Pharmacother | Present and emerging pharmacotherapies for non-alcoholic steatohepatitis in adults. | 2018 | Details |
| A12535 | 30404689 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | [Nonalcoholic Fatty Liver Disease and Weight Loss]. | 2018 | Details |
| A12549 | 30398639 | Ann Intern Med | Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12562 | 30390263 | Adv Exp Med Biol | Sarcopenia in Liver Disease: Current Evidence and Issues to Be sResolved. | 2019 | Details |
| A12583 | 30377993 | J Microbiol | Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics. | 2018 | Details |
| A12588 | 30374329 | Front Endocrinol (Lausanne) | Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms. | 2018 | Details |
| A12613 | 30363947 | Oxid Med Cell Longev | Treatment of NASH with Antioxidant Therapy: Beneficial Effect of Red Cabbage on Type 2 Diabetic Rats. | 2018 | Details |
| A12651 | 30347485 | Liver Int | Longitudinal analysis of risk of non-alcoholic fatty liver disease in adulthood. | 2019 | Details |
| A12671 | 30335697 | Transplantation | Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. | 2019 | Details |
| A12712 | 30318268 | Psychosomatics | Psychosocial Issues in Pediatric Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12727 | 30314924 | Clin Nutr | Critical appraisal for low-carbohydrate diet in nonalcoholic fatty liver disease: Review and meta-analyses. | 2018 | Details |
| A12729 | 30314377 | Pharmaceuticals (Basel) | Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A12752 | 30300961 | Liver Int | Periodontitis is associated with incident chronic liver disease-A population-based cohort study. | 2018 | Details |
| A12755 | 30300289 | Transplantation | Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis. | 2019 | Details |
| A12773 | 30294278 | Front Physiol | Cell-Free Circulating Nucleic Acids as Early Biomarkers for NAFLD and NAFLD-Associated Disorders. | 2018 | Details |
| A12782 | 30290973 | J Hepatol | An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers. | 2018 | Details |
| A12787 | 30288073 | Diabetes Metab Syndr Obes | Obesity and nonalcoholic fatty liver disease: current perspectives. | 2018 | Details |
| A12799 | 30283242 | Am J Lifestyle Med | Prevention of Diabetes: Countless Opportunities and Clear Challenges. | 2017 | Details |
| A12808 | 30274326 | Diseases | When to Initiate Weight Loss Medications in the NAFLD Population. | 2018 | Details |
| A12814 | 30272604 | Gastroenterol Nurs | The Role of the Nurse Practitioner in the Management of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A12817 | 30270688 | Scand J Gastroenterol | Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study. | 2018 | Details |
| A12830 | 30264828 | AIDS Rev | Non-Alcoholic Fatty Liver Disease in Patients with HIV Infection | 2018 | Details |
| A12845 | 30258096 | Lab Invest | Activation of brown adipose tissue enhances the efficacy of caloric restriction for treatment of nonalcoholic steatohepatitis. | 2018 | Details |
| A12881 | 30244334 | Curr Gastroenterol Rep | Treatment of NASH with Gastric Bypass. | 2018 | Details |
| A12898 | 30235807 | Diseases | Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD. | 2018 | Details |
| A12906 | 30231359 | Am Soc Clin Oncol Educ Book | Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma. | 2018 | Details |
| A12915 | 30228727 | Mo Med | NASH: The Emerging Most Common Form of Chronic Liver Disease. | 2019 | Details |
| A12939 | 30217048 | Nutrients | Aerobic Physical Activity and a Low Glycemic Diet Reduce the AA/EPA Ratio in Red Blood Cell Membranes of Patients with NAFLD. | 2018 | Details |
| A13018 | 30179269 | Hepatology | Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2019 | Details |
| A13041 | 30170074 | Diabetes Res Clin Pract | Non-alcoholic fatty liver disease: Relationship with cardiovascular risk markers and clinical endpoints. | 2018 | Details |
| A13058 | 30158570 | Nat Rev Gastroenterol Hepatol | The changing epidemiology of liver diseases in the Asia-Pacific region. | 2019 | Details |
| A13076 | 30148144 | World J Clin Cases | PNPLA3 rs738409 underlies treatment response in nonalcoholic fatty liver disease. | 2018 | Details |
| A13089 | 30142943 | Nutrients | Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence. | 2018 | Details |
| A13092 | 30142427 | J Hepatol | Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A13120 | 30131212 | Trends Endocrinol Metab | Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A13122 | 30129816 | Metab Syndr Relat Disord | Relationship Between Handgrip Strength and Nonalcoholic Fatty Liver Disease: Nationwide Surveys. | 2018 | Details |
| A13140 | 30120405 | Pediatr Res | Hepatic fat content and bone mineral density in children with overweight/obesity. | 2018 | Details |
| A13148 | 30115487 | J Diabetes Complications | Body fat, metabolic syndrome and hyperglycemia in South Asians. | 2018 | Details |
| A13228 | 30074500 | Curr Opin Endocrinol Diabetes Obes | Nonalcoholic steatohepatitis, obesity, and cardiac dysfunction. | 2018 | Details |
| A13249 | 30064987 | Gut | Association of dietary macronutrient composition and non-alcoholic fatty liver disease in an ageing population: the Rotterdam Study. | 2018 | Details |
| A13263 | 30060482 | Nutrients | Beneficial and Paradoxical Roles of Anti-Oxidative Nutritional Support for Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A13319 | 30033779 | Expert Rev Gastroenterol Hepatol | Health benefits of Mediterranean diet in nonalcoholic fatty liver disease. | 2018 | Details |
| A13321 | 30032630 | Rev Esp Enferm Dig | Role of the PNPLA3 polymorphism rs738409 on silymarin + vitamin E response in subjects with non-alcoholic fatty liver disease. | 2018 | Details |
| A13327 | 30029691 | Cardiovasc Diabetol | Beneficial effects of cherry consumption as a dietary intervention for metabolic, hepatic and vascular complications in type 2 diabetic rats. | 2018 | Details |
| A13337 | 30026388 | Cold Spring Harb Mol Case Stud | Exome sequencing of an adolescent with nonalcoholic fatty liver disease identifies a clinically actionable case of Wilson disease. | 2018 | Details |
| A13349 | 30019089 | Eur J Nutr | Association between dietary total antioxidant capacity and hepatocellular ballooning in nonalcoholic steatohepatitis: a cross-sectional study. | 2018 | Details |
| A13367 | 30014320 | Hormones (Athens) | Sarcopenic obesity. | 2018 | Details |
| A13405 | 29992886 | Curr Vasc Pharmacol | Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives. | 2019 | Details |
| A13459 | 29963461 | Euroasian J Hepatogastroenterol | Nonalcoholic Fatty Liver Disease: Time to Take the Bull by the Horns. | 2018 | Details |
| A13470 | 29956213 | Adv Exp Med Biol | Current Prevention and Treatment Options for NAFLD. | 2018 | Details |
| A13481 | 29956202 | Adv Exp Med Biol | Introduction. | 2018 | Details |
| A13492 | 29951362 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease: A Review of Anti-diabetic Pharmacologic Therapies. | 2018 | Details |
| A13494 | 29949199 | J Gastroenterol Hepatol | Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients. | 2018 | Details |
| A13498 | 29947322 | Br J Nutr | Improvements in clinical characteristics of patients with non-alcoholic fatty liver disease, after an intervention based on the Mediterranean lifestyle: a randomised controlled clinical trial. | 2018 | Details |
| A13503 | 29946426 | F1000Res | Recent advances in understanding and managing non-alcoholic fatty liver disease. | 2018 | Details |
| A13510 | 29941024 | Trials | Effects of an exercise program on hepatic metabolism, hepatic fat, and cardiovascular health in overweight/obese adolescents from Bogotá, Colombia (the HEPAFIT study): study protocol for a randomized controlled trial. | 2018 | Details |
| A13524 | 29931231 | J Nutr | Daily Consumption of Synbiotic Yogurt Decreases Liver Steatosis in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial. | 2018 | Details |
| A13551 | 29915639 | Gastroenterology Res | A Case of Concomitant Obstructive Sleep Apnea and Non-Alcoholic Steatohepatitis Treated With CPAP Therapy. | 2018 | Details |
| A13612 | 29878845 | Am J Physiol Gastrointest Liver Physiol | Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis. | 2018 | Details |
| A13617 | 29873275 | Int J Immunopathol Pharmacol | Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspective. | 2018 | Details |
| A13646 | 29858436 | Clin Med (Lond) | Non-alcoholic fatty liver disease. | 2018 | Details |
| A13648 | 29857146 | Clin Gastroenterol Hepatol | Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review. | 2018 | Details |
| A13650 | 29856820 | PLoS One | Fatty liver index is a predictor of incident diabetes in patients with prediabetes: The PREDAPS study. | 2018 | Details |
| A13661 | 29851153 | J Gastroenterol Hepatol | Burden of non-alcoholic fatty liver disease in Australia. | 2018 | Details |
| A13682 | 29843404 | Medicines (Basel) | Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A13710 | 29797516 | Eur J Clin Invest | Exercising the hepatobiliary-gut axis. The impact of physical activity performance. | 2018 | Details |
| A13726 | 29788220 | Endocrinology | Obstructive Sleep Apnea Syndrome and Metabolic Diseases. | 2018 | Details |